Christopher R. Cline, CFO: Travere Therapeutics TVTX Sell · Filed 02/05

Trade details

Type: Insider sale
Amount: $52,548.9
Shares · price: 1,635 sh · $32.14 a share
Held after: 111,336 sh
Stock: Travere Therapeutics TVTX
Person: Christopher R. ClineCFO
Trade date: 26/02/04
Filed: 26/02/05
Days to filing: 1 days

Sold 1.4% of holdings

Share of holding sold: 1.4%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 01/05~03/06

Christopher R. Cline's recent trades

Christopher R. ClineCFO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$3.3M
50,508 sh
$3.3M
Filed 09/15
Traded 09/15
Christopher R. ClineCFO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$101.7K
2,181 sh
$101.7K
Filed 05/06
Traded 05/05
Christopher R. ClineCFO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$13.6K
310 sh
$13.6K
Filed 05/06
Traded 05/06
Christopher R. ClineCFO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$13.6K
310 sh
$13.6K
Filed 05/06
Traded 05/06
Christopher R. ClineCFO
Planned saleTravere Therapeutics
Planned sale
Travere Therapeutics
TVTX
$101.7K
2,181 sh
$101.7K
Filed 05/05
Traded 05/05

Christopher R. Cline, CFO — sold $52.5K of Travere Therapeutics TVTX · 1.4% of holdings · 10b5-1 plan | Whalegun